Following a thorough and selective nationwide search, Bastien Gerby has landed a prestigious position as staff investigator at the CNRS in France. Formerly a postdoctoral fellow in the Hematopoiesis and Leukemia research unit run by Dr. Trang Hoang, Principal Investigator at the IRIC, his work led to identifying pre-leukemic stem cells that cause T-acute lymphoblastic leukemia (T-ALL).

These cells are of great clinical interest because they are resistant to conventional chemotherapy treatment. As a result, this work led to developing an innovative protocol for screening thousands of chemical components on those cells and to identifying a molecule that would eliminate them more effectively than current drugs. The research results that have come from Dr. Trang Hoang’s lab were recognized as one of the greatest advances in the field of stem cells in Canada in 2016 by the Canadian Cancer Society.

Drawing on his multidisciplinary research experience supported by the cutting-edge technological core facilities at the IRIC, Bastien Gerby now carries on his activity as a young investigator at the Oncopôle de Toulouse in France in order to develop an innovative therapeutic approach for treating myelodysplastic syndrome and acute myeloid leukemia.